Science and tech development group Allied Minds plans a $140 million initial public offering on the London Stock Exchange in support of commercializing innovations coming out of U.S. research institutions. Boston-based innovation development group Allied Minds is planning a $140 million (£83 million) initial public offering on the London Stock Exchange in support of its effort to commercialize products in the U.S. Allied Minds CEO Chris Silva called the offering is “a major strategic step” for the firm, which in 2011 formed a medtech-focused subsidiary to develop new devices originating from U.S. universities and federally funded research institutions.
Help employers find you! Check out all the jobs and post your resume.
